PEPTIDE DOSAGE CHART

Use the chart to quickly reference dose, frequency, timing, typical duration, and additional notes for each peptide.

Peptide Dosage & Reconstitution Chart

Compare vial size, BAC water, U-100 insulin syringe units per dose, timing, frequency, and typical duration.

PeptideResearch FocusVial SizeBAC WaterDose Amount
(U-100 Syringe Units)
TimingFrequencyTypical DurationHelpful Note
BPC-157Recovery10 mg2 mL10 unitsAnytime1–2 times daily8–12 weeksOften paired with TB-500.
TB-500Recovery10 mg1 mL25 unitsAnytime2 times weekly4–8 weeksCommonly discussed for systemic recovery.
IpamorelinWeight / GH10 mg3 mL9 unitsAM / PM5 days on, 2 days off8 weeks on, 8 weeks offFrequently paired with CJC-1295 No DAC.
TesamorelinBody Composition10 mg2 mL20 unitsAM / PM5 days on, 2 days off8 weeks on, 8 weeks offApproved formulations use product-specific instructions.
AOD-9604Weight Management10 mg2 mL6 unitsAM5 days on, 2 days off8 weeks on, 8 weeks offOften discussed in fasted protocols.
SemaglutideWeight Management10 mg2 mL5 unitsSame day weeklyOnce weekly8 weeks on, 8 weeks offApproved products use gradual titration.
TirzepatideWeight Management10 mg1 mL25 unitsSame day weeklyOnce weekly8 weeks on, 8 weeks offApproved products use stepwise dose escalation.
MOTS-CMetabolism10 mg2 mL40 unitsAMEvery 3rd day2 weeksOften discussed in energy and endurance research.
CJC-1295 No DACLongevity / GH10 mg3 mL6 unitsPM5 days on, 2 days off8 weeks on, 8 weeks offShorter acting; often paired with Ipamorelin.
CJC-1295 DACLongevity / GH10 mg1 mL10 unitsAnytimeOnce weekly12–24 weeksLonger-acting DAC version.
EpithalonLongevity10 mg1 mL50 unitsAM3 days per week3 weeks straight, once yearlyUsually discussed in short research cycles.
ThymalinLongevity / Immune10 mg1 mL50 unitsAM20 days straightOnce every 6 monthsThymic peptide preparation.
Melanotan IIPigmentation10 mg3 mL7.5 unitsPM2 days per week8 weeks on, 8 weeks offNausea and flushing are often mentioned.
GHK-CuSkin & Hair10 mg2 mL40 unitsAnytimeOnce daily4–8 weeksSite rotation is commonly noted.
SermorelinLongevity / GH10 mg3 mL9 unitsPMOnce daily12–24 weeksCommonly associated with nighttime protocols.
GHRP-2Growth Hormone10 mg3 mL4.5 unitsFasted1–3 times daily12–24 weeksMay be associated with increased appetite.
GHRP-6Growth Hormone10 mg3 mL4.5 unitsFasted1–3 times daily12–24 weeksOften noted for a stronger appetite response.
HexarelinGrowth Hormone10 mg3 mL4.5 unitsFasted1–2 times daily4–8 weeksShorter cycles are often discussed.
PT-141Sexual Function10 mg1 mL15 unitsSeveral hours beforeAs neededIntermittentApproved bremelanotide has specific frequency limits.
DSIPSleep10 mg3 mL7.5 unitsAbout 3 hours before bedAs neededShort termExperimental sleep-related peptide.
Educational Notice: The Dose Amount column shows how many units would be drawn on a U-100 insulin syringe after reconstituting the displayed 10 mg vial with the listed amount of BAC water. These calculations are provided as an educational reference based on the chart inputs shown. Peptide Knowledge Center does not provide medical advice or individualized treatment recommendations. Formulations, concentrations, and protocols may vary.

Peptide DOSing, TIMING & FREQUENCY

Peptide dosing can vary widely from one compound to another. Dose amounts, frequency, timing, and duration all play a role in how different peptides appear in research and established clinical use.

The Peptide Dosage Chart puts those details side by side, giving you one place to quickly reference and compare dosing information across commonly researched peptides.

View the Dosage Chart

MORE THAN JUST A NUMBER

A dose by itself doesn’t tell the whole story. Frequency, timing, and duration all help provide context for how a peptide has been studied or used.

DOSE & FREQUENCY

Doses may be expressed in mcg or mg, while frequency tells you how often administration occurred within a particular protocol. Both can vary considerably between peptides.

TIMING

Morning, evening, fasted, with food — timing is often discussed alongside peptides. Where relevant, the chart identifies timing associated with established use or research protocols.

DURATION

Research may examine a peptide for days, weeks, or months. The duration shown provides context for the time periods associated with available protocols rather than establishing a universal cycle.

WHAT DO ALL THOSE MEASUREMENTS MEAN?

Peptide information often includes several types of measurements, and they don’t all describe the same thing.

mcg and mg describe an amount of a substance, while mL describes liquid volume. Syringe units are markings used to measure liquid volume on certain syringes.

The amount of a peptide and the volume of liquid containing it are related through concentration — which is why a dose listed in mcg or mg cannot automatically be converted into syringe units without additional information.

For help with those measurements, visit the Syringe Unit Converter or Peptide Reconstitution Calculator

MCG. MG. ML. UNITS.
THEY DON’T MEAN THE SAME THING.

Each measurement tells you something different about the amount or volume.

WHAT ABOUT CYCLES & TIME OFF?

You’ll often see peptide discussions refer to a cycle, a certain number of weeks “on,” or a period of time “off.” These schedules can vary depending on the peptide, the research being conducted, and the purpose of the protocol.

Some studies include defined treatment periods followed by observation or washout periods, while others involve continued administration throughout the study. For many investigational peptides, there is no established human schedule for how long a peptide should be used or how much time should pass between cycles.

The Typical Duration included in our chart provides context based on available research or established use rather than a universal recommendation.

RESEARCH KEEPS MOVING

Peptide research continues to evolve, and the information available today may change as new studies are published and compounds are examined more closely. This chart is designed to grow along with that research, giving you a central place to reference the latest information we can reliably support.

Educational Use Notice: Information provided by Peptide Knowledge Center is for educational purposes only and is not medical advice or a recommendation for treatment or self-administration. Some peptides discussed are investigational and do not have established dosing for human use.